ORLANDI, ENRICO

ORLANDI, ENRICO  

Mostra records
Risultati 1 - 7 di 7 (tempo di esecuzione: 0.019 secondi).
Titolo Data di pubblicazione Autore(i) File
A long-term time course of colorimetric assessment of the effects of imatinib mesylate on skin pigmentation: a study of five patients 1-gen-2007 Brazzelli, V; Prestinari, F; Barbagallo, T; Rona, Claudia; Orlandi, E; Passamonti, F; Locatelli, F; Zecca, M; Villani, S; Borroni, G.
Gynecological radio-induced secondary malignancy after a gynecological primary tumor: a rare entity and a challenge for oncologists 1-gen-2022 Barcellini, A.; Dominoni, M.; Gardella, B.; Mangili, G.; Orlandi, E.
Hand in hand: A multistakeholder approach for co-production of surgical care 1-gen-2022 Cobianchi, L.; Dal Mas, F.; Massaro, M.; Bednarova, R.; Biancuzzi, H.; Filisetti, C.; Barcellini, A.; Orlandi, E.; Miceli, L.; Angelos, P.
Immunonutrition in head and neck cancer patients undergoing chemoradiotherapy: An alternative approach for overcoming potential bias 1-gen-2021 Caccialanza, R.; Cereda, E.; Orlandi, E.; Filippi, A. R.; Comoli, P.; Alberti, A.; Imarisio, I.; Pedrazzoli, P.; Bossi, P.
Omentum flap as a spacer before carbon ion radiotherapy for gynecological recurrences. A technical note 1-gen-2022 Barcellini, A; Mirandola, A; Fiore, M R; Orlandi, E; Cobianchi, L
Please mind the gap-about equity and access to care in oncology 1-gen-2021 Barcellini, A; Dal Mas, F; Paoloni, P; Loap, P; Cobianchi, L; Locati, L; Rodríguez-Luna, M R; Orlandi, E
Preoperative Carbon Ion Radiotherapy (CIRT) with Chemotherapy in Resectable and Borderline Resectable Pancreatic Adenocarcinoma (PCa): A Multicenter Prospective Phase II Clinical Study (Pioppo Study NCT 03822936) 1-gen-2023 Barcellini, A.; Vitolo, V.; Cobianchi, L.; Vanoli, A.; Butturini, G.; Brugnatelli, S.; Pagani, A.; Fossati, P.; Preda, L.; Peloso, A.; Klersy, C.; Facoetti, A.; Molinelli, S.; Ciocca, M.; Imparato, S.; Pecorilla, M.; Orlandi, E.; Valvo, F.